[go: up one dir, main page]

EP3199097A3 - Ametropia treatment tracking methods and system - Google Patents

Ametropia treatment tracking methods and system Download PDF

Info

Publication number
EP3199097A3
EP3199097A3 EP17153507.3A EP17153507A EP3199097A3 EP 3199097 A3 EP3199097 A3 EP 3199097A3 EP 17153507 A EP17153507 A EP 17153507A EP 3199097 A3 EP3199097 A3 EP 3199097A3
Authority
EP
European Patent Office
Prior art keywords
estimating
expected
trajectory
tracking methods
ametropia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP17153507.3A
Other languages
German (de)
French (fr)
Other versions
EP3199097A2 (en
EP3199097B1 (en
Inventor
Noel A. Brennan
Khaled Chehab
Eric A. RITCHEY
Lisa A. Jones-Jordan
Loraine T. Sinnott
Xu Cheng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Vision Care Inc
Original Assignee
Johnson and Johnson Vision Care Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Vision Care Inc filed Critical Johnson and Johnson Vision Care Inc
Publication of EP3199097A2 publication Critical patent/EP3199097A2/en
Publication of EP3199097A3 publication Critical patent/EP3199097A3/en
Application granted granted Critical
Publication of EP3199097B1 publication Critical patent/EP3199097B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/024—Methods of designing ophthalmic lenses
    • G02C7/027—Methods of designing ophthalmic lenses considering wearer's parameters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/0016—Operational features thereof
    • A61B3/0025—Operational features thereof characterised by electronic signal processing, e.g. eye models
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/0016—Operational features thereof
    • A61B3/0033—Operational features thereof characterised by user input arrangements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/0016—Operational features thereof
    • A61B3/0041—Operational features thereof characterised by display arrangements
    • A61B3/0058—Operational features thereof characterised by display arrangements for multiple images
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/103—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for determining refraction, e.g. refractometers, skiascopes
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/024—Methods of designing ophthalmic lenses
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04—Contact lenses for the eyes
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C2202/00—Generic optical aspects applicable to one or more of the subgroups of G02C7/00
    • G02C2202/24—Myopia progression prevention
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pathology (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Signal Processing (AREA)
  • Eye Examination Apparatus (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Eyeglasses (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)

Abstract

A method for estimating and tracking refractive error progression of an individual includes estimating a percentile of Spherical Equivalent Refraction (SPHEQ) as a function of at least the individual's age by comparison to a reference population; estimating an expected SPHEQ trajectory over a future predetermined period of time; comparing the expected SPHEQ trajectory with the reference population; and comparing the expected SPHEQ trajectory with an expected SPHEQ trajectory using an ametropia control treatment, thereby showing a possible treatment benefit over the predetermined period of time.
EP17153507.3A 2016-01-27 2017-01-27 Ametropia treatment tracking methods and system Active EP3199097B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15/007,660 US10042181B2 (en) 2016-01-27 2016-01-27 Ametropia treatment tracking methods and system

Publications (3)

Publication Number Publication Date
EP3199097A2 EP3199097A2 (en) 2017-08-02
EP3199097A3 true EP3199097A3 (en) 2017-08-30
EP3199097B1 EP3199097B1 (en) 2024-02-21

Family

ID=57960257

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17153507.3A Active EP3199097B1 (en) 2016-01-27 2017-01-27 Ametropia treatment tracking methods and system

Country Status (6)

Country Link
US (2) US10042181B2 (en)
EP (1) EP3199097B1 (en)
JP (1) JP6843629B2 (en)
KR (1) KR102756915B1 (en)
CN (1) CN107028586B (en)
RU (1) RU2664173C2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10912456B2 (en) * 2016-01-27 2021-02-09 Johnson & Johnson Vision Care, Inc. Ametropia treatment tracking methods and system
US10042181B2 (en) 2016-01-27 2018-08-07 Johnson & Johnson Vision Care, Inc. Ametropia treatment tracking methods and system
JP7057186B2 (en) * 2018-03-28 2022-04-19 株式会社トプコン Ophthalmology equipment and ophthalmology information processing program
US10909866B2 (en) * 2018-07-20 2021-02-02 Cybernet Systems Corp. Autonomous transportation system and methods
SG11202105576SA (en) * 2018-12-21 2021-07-29 Essilor Int A method and device for predicting evolution over time of a vision-related parameter
BR112021010770A2 (en) * 2018-12-21 2021-09-08 Essilor International METHOD AND DEVICE FOR CONSTRUCTING A MODEL TO PREDICT THE EVOLUTION OVER TIME OF A VISION-RELATED PARAMETER AND COMPUTER-READABLE NON-TRANSITORY STORAGE MEDIA
CN109620124A (en) * 2019-01-28 2019-04-16 合肥华科电子技术研究所 A kind of campus vision monitoring system
KR102250775B1 (en) 2019-10-18 2021-05-11 주식회사 에스알파테라퓨틱스 Digital apparatus and application for treating myopia
GB201918993D0 (en) 2019-12-20 2020-02-05 Univ Dublin Technological A system and method of determining the ocular biometric status of a patient
EP3865046B1 (en) * 2020-02-12 2025-09-03 Essilor International Detecting and correcting a variation of current refractive error and of current accommodation amplitude of a person
CN112289446A (en) * 2020-10-29 2021-01-29 美视(杭州)人工智能科技有限公司 A computer system for predicting teenage myopia
US20240047037A1 (en) * 2020-12-18 2024-02-08 Essilor International System and method for determining a modification or a change of an initial myopia control solution used by a myopic subject
AU2021403600A1 (en) * 2020-12-18 2023-06-15 Essilor International System and method for determining an appropriate moment for modifying or changing an initial myopia control solution
US20230081566A1 (en) * 2021-09-03 2023-03-16 Johnson & Johnson Vision Care, Inc. Systems and methods for predicting myopia risk
KR102870907B1 (en) * 2021-11-03 2025-10-15 주식회사 티아이 Method and apparatus for providing information necessary for myopia treatment using predicted refraction
EP4194933A1 (en) * 2021-12-10 2023-06-14 Essilor International System and method for determining a myopia control solution used by a subject
WO2023143711A1 (en) 2022-01-26 2023-08-03 Kaymak Hakan Method and system for the treatment of progressing myopia
CN114974582B (en) * 2022-05-05 2025-03-25 北京大学 Myopia risk prediction method, device, electronic device and medium
WO2025233803A1 (en) * 2024-05-10 2025-11-13 Johnson & Johnson Vision Care, Inc. Myopic control progression modeling, tracking, and/or treatment

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6045578A (en) * 1995-11-28 2000-04-04 Queensland University Of Technology Optical treatment method
EP1967892A1 (en) * 2007-03-09 2008-09-10 Auckland Uniservices Limited Contact lens and method of preventing or slowing myopia progression
WO2015070092A1 (en) * 2013-11-07 2015-05-14 Amo Development Llc Treatment validation systems and methods

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001522679A (en) * 1997-11-14 2001-11-20 ブラウン、スチュアート Automatic light reflection screening
CA2362129C (en) 1999-02-12 2006-10-03 Hoya Corporation Spectacle lens and manufacturing method therefor
US6626538B1 (en) * 2000-07-12 2003-09-30 Peter N. Arrowsmith Method for determining the power of an intraocular lens used for the treatment of myopia
US6582078B2 (en) 2001-02-27 2003-06-24 Barton L. Halpern Method and system for planning corrective refractive surgery
DE04759430T1 (en) * 2003-04-11 2006-07-13 Bausch & Lomb Incorporated METHOD, SYSTEM AND ALGORITHM RELATED TO THE TREATMENT PLANNING FOR SEE CORRECTION
US7766478B2 (en) * 2004-07-01 2010-08-03 Auckland Uniservices Limited Contact lens and method for prevention of myopia progression
ITFI20080081A1 (en) * 2008-04-18 2009-10-19 Strumenti Oftalmici C S O S R PROCEDURE AND SYSTEM FOR THE RECORDING OF MULTIFOCAL ERG, PERG AND VEP ELECTROFUNCTIONAL REPLIES IN REAL TIME
FI20090085A7 (en) * 2009-03-06 2010-09-30 Kone Corp Elevator arrangement and method
ES2676393T3 (en) * 2011-01-14 2018-07-19 University Of Washington Through Its Center For Commercialization Methods to diagnose and prescribe a treatment protocol for disorders related to eye length
EP2902839A4 (en) 2012-09-25 2016-05-25 Univ Osaka CONTACT LENS FOR ENHANCING THE EVOLUTION OF MYOPIA, AND SET OF CONTACT LENSES FOR ENHANCING THE EVOLUTION OF MYOPIA
US9201250B2 (en) * 2012-10-17 2015-12-01 Brien Holden Vision Institute Lenses, devices, methods and systems for refractive error
SG11201506655YA (en) 2013-03-01 2015-09-29 Essilor Int Method of evaluating the efficiency of a myopia control product
WO2015013044A1 (en) * 2013-07-25 2015-01-29 Optimedica Coporation In situ determination of refractive index of materials
US9753309B2 (en) * 2013-11-04 2017-09-05 Myopiaok Limited Contact lens and method for prevention of myopia progression
JP5667730B1 (en) * 2013-12-09 2015-02-12 株式会社ユニバーサルビュー Myopia progression diagnostic device, myopia progression determination method, program, and storage medium
WO2015087435A1 (en) 2013-12-09 2015-06-18 株式会社ユニバーサルビュー Myopia progress diagnostic device, myopia progress assessment method, program, and storage medium
RU2567273C1 (en) * 2014-05-06 2015-11-10 Лев Павлович Чередниченко Method of early determination of abnormal refractogenesis in children
KR20160006893A (en) 2014-07-09 2016-01-20 희성전자 주식회사 Method of manufacturing a touch panel
US9638936B2 (en) * 2014-08-20 2017-05-02 Johnson & Johnson Vision Care, Inc. High plus treatment zone lens design for preventing and/or slowing myopia progression
WO2016187426A1 (en) * 2015-05-19 2016-11-24 Amorphex Therapeutics Llc A device that delivers a sustained low-dose of a myopia-suppressing drug
US10042181B2 (en) 2016-01-27 2018-08-07 Johnson & Johnson Vision Care, Inc. Ametropia treatment tracking methods and system

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6045578A (en) * 1995-11-28 2000-04-04 Queensland University Of Technology Optical treatment method
EP1967892A1 (en) * 2007-03-09 2008-09-10 Auckland Uniservices Limited Contact lens and method of preventing or slowing myopia progression
WO2015070092A1 (en) * 2013-11-07 2015-05-14 Amo Development Llc Treatment validation systems and methods

Also Published As

Publication number Publication date
CN107028586B (en) 2021-05-28
KR102756915B1 (en) 2025-01-21
EP3199097A2 (en) 2017-08-02
RU2017101996A (en) 2018-07-23
US10642067B2 (en) 2020-05-05
KR20170089771A (en) 2017-08-04
JP6843629B2 (en) 2021-03-17
RU2017101996A3 (en) 2018-07-23
RU2664173C2 (en) 2018-08-15
US10042181B2 (en) 2018-08-07
JP2017138977A (en) 2017-08-10
EP3199097B1 (en) 2024-02-21
CN107028586A (en) 2017-08-11
US20180140181A1 (en) 2018-05-24
US20170209036A1 (en) 2017-07-27

Similar Documents

Publication Publication Date Title
EP3199097A3 (en) Ametropia treatment tracking methods and system
EP3012756A3 (en) Computing weight control profile
EP3225154A3 (en) Gaze detection apparatus and gaze detection method
CA3002435A1 (en) Ametropia treatment tracking methods and system
WO2012129507A8 (en) Adaptive analytical behavioral and health assistant system and related method of use
HK1252588A1 (en) Tilt shift iris imaging
WO2015128803A3 (en) System and method for auto-contouring in adaptive radiotherapy
MX2018012608A (en) Systems and devices for motion tracking, assessment, and monitoring and methods of use thereof.
EP3943611A3 (en) Predictive neurodiagnostic methods
EP3590406A4 (en) MEDICAL OBSERVATION SYSTEM, CONTROL DEVICE AND CONTROL METHOD
EP4445870A3 (en) Ophthalmic devices, system and methods that improve peripheral vision
EP4233936A3 (en) Insulin delivery systems and methods
EP2497547A3 (en) Information processing program, information processing apparatus, information processing system, and information processing method
WO2010100567A3 (en) System and method for determining emotional response to olfactory stimuli
MY180872A (en) Eye gaze tracking
WO2019108555A8 (en) Models for targeted sequencing
EP4553565A3 (en) Computerized refraction and astigmatism determination
WO2012138871A3 (en) Image analysis for specific objects
WO2016049090A3 (en) System and method to assist a user in achieving a goal
WO2015164456A3 (en) Gait analysis devices, methods, and systems
EP3144720A3 (en) Contact lens product
WO2013052132A3 (en) Image-based head position tracking method and system
EP2567869A3 (en) Vehicle-mounted device identifying apparatus
EP3970155A4 (en) Computer-implemented system and methods for predicting the health and therapeutic behavior of individuals using artificial intelligence, smart contracts and blockchain
WO2020180454A3 (en) Method for estimating core body temperature

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 3/00 20060101ALI20170724BHEP

Ipc: A61B 5/00 20060101ALI20170724BHEP

Ipc: A61B 3/103 20060101AFI20170724BHEP

Ipc: G06F 19/00 20110101ALI20170724BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180222

RBV Designated contracting states (corrected)

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1239497

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20210430

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230522

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20230908

RIC1 Information provided on ipc code assigned before grant

Ipc: G16H 50/50 20180101ALI20230825BHEP

Ipc: A61B 3/00 20060101ALI20230825BHEP

Ipc: A61B 5/00 20060101ALI20230825BHEP

Ipc: A61B 3/103 20060101AFI20230825BHEP

RIN1 Information on inventor provided before grant (corrected)

Inventor name: CHENG, XU

Inventor name: SINNOTT, LORAINE T.

Inventor name: JONES-JORDAN, LISA A.

Inventor name: RITCHEY, ERIC A.

Inventor name: CHEHAB, KHALED

Inventor name: BRENNAN, NOEL A.

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602017079288

Country of ref document: DE

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20240221

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240621

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240522

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1658336

Country of ref document: AT

Kind code of ref document: T

Effective date: 20240221

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240521

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240521

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240521

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240621

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240522

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240621

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240621

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602017079288

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20241205

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20241209

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IE

Payment date: 20241209

Year of fee payment: 9

26N No opposition filed

Effective date: 20241122

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20241203

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20241210

Year of fee payment: 9

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240221

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20250127

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20250131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20250131

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20250131